Back to products

Lamivudine Stavudine Nevirapine Tablets
$6.30 – $18.89Price range: $6.30 through $18.89
Cefpodoxime Ofloxacin Tablets
$33.11 – $99.33Price range: $33.11 through $99.33
Available Options
Tablets | Price | Description | Quantity | |
---|---|---|---|---|
100 Tablets | $0.33/piece | |||
200 Tablets | $0.33/piece | |||
300 Tablets | $0.33/piece |
Cefpodoxime Proxetil + Ofloxacin is a combination of two antibiotics: Cefpodoxime Proxetil and Ofloxacin. Cefpodoxime Proxetil works by preventing the formation of the bacterial protective covering, which is essential for the survival of the bacteria in the human body. Ofloxacin works by preventing the bacteria from reproducing and repairing themselves. Together, they treat your infection effectively.
SKU:
N/A
Categories: Antibiotics, Generic & Branded Medicines Manufacturing, Generic Antibiotics
Description
Brand | ZEDOCEF |
Packaging Size | 10*10TABLETS |
Form | Tablet |
Composition | Cefpodoxime Of loxacin |
Alsogives | PCDPharma, ThirdParty Pharma |
Alsogives | MACLEODS |
Uses | ANTIBIOTIC |
Storageconditions | KEEPINADRYPLACE |
Country of Origin | Made in India |
Additional information
Tablets |
100 Tablets ,200 Tablets ,300 Tablets |
---|
Reviews (0)
Be the first to review “Cefpodoxime Ofloxacin Tablets” Cancel reply
Related products
6-MP 50 Mg (Mercaptopurine)
Rated 0 out of 5
In stock
$7.80 – $71.00Price range: $7.80 through $71.00
Select options
This product has multiple variants. The options may be chosen on the product page
Anaridex 1 Mg (Anastrozole)
Rated 0 out of 5
In stock
$43.80 – $203.80Price range: $43.80 through $203.80
Select options
This product has multiple variants. The options may be chosen on the product page
Gelusil MPS Antacid & Antigas Original Liquid
Rated 0 out of 5
In stock
Uma Ayurveda Anu Tail
Rated 0 out of 5
In stock
Ziverdo Kit
Rated 0 out of 5
In stock
$55.00 – $347.00Price range: $55.00 through $347.00
Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.